Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (41-50 of 257) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|March 21, 2017
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous ThromboembolismMark A Crowther, Adam Cuker
Drug Discovery Today|June 1, 2014
Reversal of target-specific oral anticoagulantsDeborah M Siegal, Adam Cuker
Hematology. American Society of Hematology. Education Program|December 10, 2021
Heparin-induced thrombocytopenia and cardiovascular surgeryAllyson M Pishko, Adam Cuker
Blood|January 17, 2012
How I treat heparin-induced thrombocytopeniaAdam Cuker, Douglas B Cines
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: Is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?Adam Cuker, Douglas B Cines
Kardiologia Polska|May 24, 2021
Laboratory assessment of the direct oral anticoagulants: who can benefit?Imo J Akpan, Adam Cuker
Journal of Critical Care|May 6, 2014
The 4Ts test in the critically ill: timing is everythingChristine M McMahon, Adam Cuker
Polish Archives of Internal Medicine|January 2, 2025
Anticoagulation in patients with a history of heparin-induced thrombocytopenia who require cardiovascular surgery: is it okay to use heparin?Saarang R Deshpande, Adam Cuker
Aesthetic Surgery Journal|September 6, 2015
Commentary on: Rivaroxaban for Venous Thromboembolism Prophylaxis in Abdominoplasty: A Multicenter ExperienceChristopher J Pannucci, Adam Cuker
Blood Reviews|September 15, 2016
Measurement and reversal of the direct oral anticoagulantsBethany T Samuelson, Adam Cuker
Pageof 26

Showing results (41-50 of 257) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|March 21, 2017
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous ThromboembolismMark A Crowther, Adam Cuker
Drug Discovery Today|June 1, 2014
Reversal of target-specific oral anticoagulantsDeborah M Siegal, Adam Cuker
Hematology. American Society of Hematology. Education Program|December 10, 2021
Heparin-induced thrombocytopenia and cardiovascular surgeryAllyson M Pishko, Adam Cuker
Blood|January 17, 2012
How I treat heparin-induced thrombocytopeniaAdam Cuker, Douglas B Cines
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: Is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?Adam Cuker, Douglas B Cines
Kardiologia Polska|May 24, 2021
Laboratory assessment of the direct oral anticoagulants: who can benefit?Imo J Akpan, Adam Cuker
Journal of Critical Care|May 6, 2014
The 4Ts test in the critically ill: timing is everythingChristine M McMahon, Adam Cuker
Polish Archives of Internal Medicine|January 2, 2025
Anticoagulation in patients with a history of heparin-induced thrombocytopenia who require cardiovascular surgery: is it okay to use heparin?Saarang R Deshpande, Adam Cuker
Aesthetic Surgery Journal|September 6, 2015
Commentary on: Rivaroxaban for Venous Thromboembolism Prophylaxis in Abdominoplasty: A Multicenter ExperienceChristopher J Pannucci, Adam Cuker
Blood Reviews|September 15, 2016
Measurement and reversal of the direct oral anticoagulantsBethany T Samuelson, Adam Cuker
Pageof 26